Seborrheic Keratosis Market Research Report - Forecast to 2027

Seborrheic Keratosis Market Research Information: By Type (Reticulated, Stucco, Clonal, Dermatosis Papulosa Nigra, Others), Diagnosis (Skin Biopsy, Others), Treatment (Medication, Surgery, Laser Therapy), Distribution Channel - Global Forecast Till 2027

ID: MRFR/Pharma/4313-HCR | February 2021 | Region: Global | 100 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Seborrheic Keratosis Market, by Type

6.1 Introduction

6.2 Common Seborrheic Keratosis

6.2.1 Market Estimates & Forecast, 2020–2027

6.3 Reticulated Seborrheic Keratosis or Adenoid Seborrheic Keratosis

6.3.1 Market Estimates & Forecast, 2020–2027

6.4 Stucco Keratosis

6.4.1 Market Estimates & Forecast, 2020–2027

6.5 Clonal Seborrheic Keratosis

6.5.1 Market Estimates & Forecast, 2020–2027

6.6 Irritated Seborrheic Keratosis

6.6.1 Market Estimates & Forecast, 2020–2027

6.7 Seborrheic Keratosis with Squamous Atypia

6.7.1 Market Estimates & Forecast, 2020–2027

6.8 Melanoacanthoma

6.8.1 Market Estimates & Forecast, 2020–2027

6.9 Dermatosis Papulosa Nigra

6.9.1 Market Estimates & Forecast, 2020–2027

6.10 Inverted Follicular Keratosis

6.10.1 Market Estimates & Forecast, 2020–2027

Chapter 7. Global Seborrheic Keratosis Market, by Diagnosis

7.1 Introduction

7.2 Skin Biopsy

7.2.1 Market Estimates & Forecast, 2020–2027

7.3 Others

7.3.1 Market Estimates & Forecast, 2020–2027

Chapter 8. Global Seborrheic Keratosis Market, by treatment

8.1 Introduction

8.2 Medication

8.2.1 Market Estimates & Forecast, 2020–2027

8.3 Medical procedure

8.3.1 Market Estimates & Forecast, 2020–2027

8.4 Surgical Procedures

8.4.1 Market Estimates & Forecast, 2020–2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020–2027

Chapter 9. Global Seborrheic Keratosis Market, by Distribution Channel

9.1 Introduction

9.2 Hospital

9.2.1 Market Estimates & Forecast, 2020–2027

9.3 Clinics

9.3.2 Market Estimates & Forecast, 2020–2027

9.4 Pharmacies

9.4.1 Market Estimates & Forecast, 2020–2027

9.5 Diagnostic Centers

9.5.1 Market Estimates & Forecast, 2020–2027

9.6 Others

9.6.2 Market Estimates & Forecast, 2020–2027

Chapter 10. Global Seborrheic Keratosis Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Valeant

11.1.1 Company Overview

11.1.2 Types Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Allergan

11.2.1 Company Overview

11.2.2 Types Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Syneron Medical Ltd.

11.3.1 Company Overview

11.3.2 Types Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Aclaris Therapeutics

11.4.1 Company Overview

11.4.2 Types/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Cutera

11.5.1 Company Overview

11.5.2 Types Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Lumenis

11.6.1 Company Overview

11.6.2 Types Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 BECTON DICKINSON AND COMPANY

11.7.1 Overview

11.7.2 Types Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Seborrheic Keratosis Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Seborrheic Keratosis Industry Synopsis, 2020–2027

Table 2 Seborrheic Keratosis Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Seborrheic Keratosis Market, by Region, 2020–2027, (USD Million)

Table 4 Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 5 Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 6 Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 7 Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 8 North America Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 9 North America Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 10 North America Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 11 North America Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 12 U.S. Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 13 U.S. Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 U.S. Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 15 U.S. Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 16 Canada Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 17 Canada Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 18 Canada Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 19 Canada Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 20 South America Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 21 South America Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 22 South America Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 23 South America Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 24 Europe Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 25 Europe Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Europe Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 27 Europe Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 28 Western Europe Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 29 Western Europe Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 30 Western Europe Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 31 Western Europe Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 32 Eastern Europe Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 33 Eastern Europe Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 34 Eastern Europe Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 35 Eastern Europe Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 36 Asia Pacific Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 37 Asia Pacific Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 38 Asia Pacific Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 39 Asia Pacific Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

Table 40 Middle East & Africa Seborrheic Keratosis Market, by Type, 2020–2027, (USD Million)

Table 41 Middle East & Africa Seborrheic Keratosis Market, by Diagnosis, 2020–2027, (USD Million)

Table 42 Middle East & Africa Seborrheic Keratosis Market, by Treatment, 2020–2027, (USD Million)

Table 43 Middle East & Africa Seborrheic Keratosis Market, by Distribution Channel, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Seborrheic Keratosis Market

Figure 3 Segmentation Market Dynamics for Seborrheic Keratosis Market

Figure 4 Global Seborrheic Keratosis Market Share, by Type 2020

Figure 5 Global Seborrheic Keratosis Market Share, by Diagnosis 2020

Figure 6 Global Seborrheic Keratosis Market Share, by Treatment 2020

Figure 7 Global Seborrheic Keratosis Market Share, by Distribution Channel, 2020

Figure 8 Global Seborrheic Keratosis Market Share, by Region, 2020

Figure 9 North America Seborrheic Keratosis Market Share, by Country, 2020

Figure 10 Europe Seborrheic Keratosis Market Share, by Country, 2020

Figure 11 Asia Pacific Seborrheic Keratosis Market Share, by Country, 2020

Figure 12 Middle East & Africa Seborrheic Keratosis Market Share, by Country, 2020

Figure 13 Global Seborrheic Keratosis market: Company Share Analysis, 2020 (%)

Figure 14 Valeant: Key Financials

Figure 15 Valeant Segmental Revenue

Figure 16 Valeant: Geographical Revenue

Figure 17 Allergan: Key Financials

Figure 18 Allergan: Segmental Revenue

Figure 19 Allergan: Geographical Revenue

Figure 20 Syneron Medical Ltd.: Key Financials

Figure 21 Syneron Medical Ltd.: Segmental Revenue

Figure 22 Syneron Medical Ltd.: Geographical Revenue

Figure 23 Aclaris Therapeutics: Key Financials

Figure 24 Aclaris Therapeutics: Segmental Revenue

Figure 25 Aclaris Therapeutics: Geographical Revenue

Figure 26 Cutera: Key Financials

Figure 27 Cutera: Segmental Revenue

Figure 28 Cutera Geographical Revenue

Figure 29 Lumenis: Key Financials

Figure 30 Lumenis: Segmental Revenue

Figure 31 Lumenis: Geographical Revenue

Figure 32 BECTON DICKINSON AND COMPANY: Key Financials

Figure 33 BECTON DICKINSON AND COMPANY: Segmental Revenue

Figure 34 BECTON DICKINSON AND COMPANY: Geographical Revenue

Seborrheic Keratosis Market

Seborrheic Keratosis Market is expected to register a CAGR of 9.34% to reach USD 1,320.8 Million by 2027.

Segmentation

By Type Reticulated Stucco Clonal Dermatosis Papulosa Nigra Others
By Diagnosis Skin Biopsy Others
By Treatment Medication Surgery Laser Therapy

Key Players

  • Aclaris Therapeutics
  • Alma Lasers
  • Angiodynamics
  • Apira Science Inc.
  • Becton Dickinson and Company
  • Biolase Inc.
  • BioLight Technologies LLC
  • Coherent

Drivers

  • Increasing government assistance
  • rising prevalence of various skin lesions
Speak to Analyst Request a Free Sample

Seborrheic Keratosis Market Scenario


Seborrheic keratosis is one of the common noncancerous skin growths in older adults. The growths mostly appear on shoulders, back, abdomen, face, chest, and scalp. Cryosurgery is the most preferred method to remove the growth. The method uses liquid nitrogen to freeze off the growth.


Notably, rising technological advancements and increasing participation of market leaders are the key factors driving the seborrheic keratosis market. For instance, in December 2017, Aclaris Therapeutics received FDA approval for Eskata (hydrogen peroxide). Eskata is a high-concentration hydrogen peroxide-based topical solution developed for the treatment of raised seborrheic keratoses.


Various other push factors such as growing demands for aesthetics, increasing government assistance, amendments in the regulatory framework, and rising funding and reimbursement continuously contributing to the growth of the seborrheic keratosis market. The increasing demands for aesthetics along with the rising prevalence of various skin lesions is making favorable backgrounds for the market to grow.


Despite these drivers, there are some issues associated with seborrheic keratosis market. Some of the challenges in the research and development, the high cost of treatment, side effects associated with surgical & other medical procedures, and poor healthcare system in low and middle-income countries may hinder the growth of the seborrheic keratosis market to an extent.


It is estimated that the seborrheic keratosis market is expected to grow at a CAGR 9.8% during the forecast period of 2017–2023.


Research Methodology


seborrheic keratosis 


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


Segmentation


The seborrheic keratosis market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of the type, the market is segmented into common seborrheic keratosis, reticulated seborrheic keratosis or adenoid seborrheic keratosis, stucco keratosis, clonal seborrheic keratosis, irritated seborrheic keratosis, seborrheic keratosis with squamous atypia, melanoacanthoma, dermatosis papulosa nigra, and inverted follicular keratosis. The common seborrheic keratosis is further segmented into basal cell papilloma and solid seborrheic keratosis. The stucco keratosis is further segmented into digitate seborrheic keratosis, hyperkeratotic seborrheic keratosis, serrated seborrheic keratosis, and verrucous seborrheic keratosis.


On the basis of the diagnosis, the market is classified into skin biopsy and others.


On the basis of the treatment, the market is classified as surgical procedures, medication, medical procedures, and others. The surgical procedures segment is further classified into cryosurgery, electrocautery or electrosurgery, curettage, and others. The medical procedures segment is further classified into freezing, tissue scraping, laser therapy, and others.


On the basis of the distribution channels, the market is segmented into hospital, clinics, diagnostic centers, pharmacies, and others.


Regional Analysis


The Americas dominate the Seborrheic keratosis market owing to the rising awareness among people about the condition and high healthcare expenditure. According to the statistical data suggested by Centers for Disease Control and Prevention (CDC), the total health expenditure in the United States was USD 3.2 trillion in 2015. Whereas, hospital care accounted for a share of 32.3%.


High prevalence of Seborrheic keratosis is also found to be a propelling factor in the Seborrheic keratosis market. According to a study published in Journal of Drugs in Dermatology in 2015, it is found that Seborrheic keratosis is one of the common cutaneous lesions which affects more than 83 million Americans. It is also reported that among all the patients with Seborrheic keratosis, around 33% have more than 15 Seborrheic keratosis lesions and 67% have 15 or fewer Seborrheic keratosis lesions.


Europe holds the second position in the Seborrheic keratosis market. It is expected that the financial support provided by the government, and private bodies for research & development and favorable reimbursement policies in the healthcare is likely to drive the Seborrheic keratosis market in the European region.


Owing to the huge patient pool, developing healthcare technology, and rising participation of market players, are driving the Seborrheic keratosis market in Asia Pacific. The Asia Pacific is the fastest growing Seborrheic keratosis market.


Increasing healthcare expenditure is also promoting the market growth in Asia Pacific countries. As per the statistics suggested by Australian Institute of Health and Welfare, it is found that the total healthcare expenditure was around USD 170.4 billion in 2015, i.e., 3.6% higher than the expenditure of 2014


The Middle East & Africa holds the lowest market share in Seborrheic keratosis market due to lack of technical knowledge and poor medical facilities.


Key Players


Some of key the players in the seborrheic keratosis market are Aclaris Therapeutics, Alma Lasers, Angiodynamics, Inc., Apira Science Inc., Becton Dickinson and Company, Biolase Inc., BioLight Technologies LLC, Coherent, Inc., Cutera, Erchonia Corporation, Integra Miltex, IRIDEX Corp., KAI Medical, Lumenis, Quanta Systems S.p.A., Quantumpm, Syneron Medical Ltd., Theralase Inc, THOR Photomedicine, Valeant, and others.


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Seborrheic Keratosis is a noncancerous skin growth, mostly found in old adults.

Seborrheic Keratosis Market is expected to exhibit a strong 9.8% CAGR over the forecast period from 2020 to 2027.

Growing awareness about personal aesthetics is likely to be a key driver for the market.

Americas dominate the Global Seborrheic Keratosis Market.

Leading players in the Seborrheic Keratosis Market include Aclaris Therapeutics, Alma Lasers, and Cutera, among others.